Hongfeng Liang

558 total citations · 1 hit paper
22 papers, 401 citations indexed

About

Hongfeng Liang is a scholar working on Immunology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hongfeng Liang has authored 22 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Genetics and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hongfeng Liang's work include Iron Metabolism and Disorders (3 papers), Hemoglobinopathies and Related Disorders (3 papers) and Neonatal Health and Biochemistry (2 papers). Hongfeng Liang is often cited by papers focused on Iron Metabolism and Disorders (3 papers), Hemoglobinopathies and Related Disorders (3 papers) and Neonatal Health and Biochemistry (2 papers). Hongfeng Liang collaborates with scholars based in China, United States and Macao. Hongfeng Liang's co-authors include Qiaozhen Su, Huajun Wang, Xinchun Zhang, Aiping Gu, Jun Cai, Qian Wang, Xiaodong Luo, Dandan Ma, Chang An and Yanjuan Liu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Ethnopharmacology and Neuropharmacology.

In The Last Decade

Hongfeng Liang

20 papers receiving 395 citations

Hit Papers

Gut bacterial profiles in... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongfeng Liang China 9 187 65 59 58 40 22 401
Xinqiang Yao China 7 278 1.5× 53 0.8× 35 0.6× 27 0.5× 30 0.8× 11 565
Jie Han China 12 156 0.8× 81 1.2× 76 1.3× 40 0.7× 9 0.2× 29 434
Lili Zhong China 12 175 0.9× 62 1.0× 49 0.8× 17 0.3× 11 0.3× 20 485
Yaguang Hu China 12 155 0.8× 42 0.6× 71 1.2× 23 0.4× 12 0.3× 33 466
Asmaa Mohammed ShamsEldeen Egypt 13 133 0.7× 53 0.8× 39 0.7× 13 0.2× 25 0.6× 47 441
Ran An China 10 156 0.8× 61 0.9× 33 0.6× 35 0.6× 9 0.2× 31 552
Jin Zhu China 10 234 1.3× 52 0.8× 82 1.4× 40 0.7× 14 0.3× 24 476
Nairita Roy United States 10 207 1.1× 75 1.2× 46 0.8× 23 0.4× 38 0.9× 14 423
Chengshi Wang China 4 133 0.7× 38 0.6× 33 0.6× 64 1.1× 22 0.6× 6 499
Jun‐Yih Chen Taiwan 9 147 0.8× 124 1.9× 18 0.3× 29 0.5× 43 1.1× 15 366

Countries citing papers authored by Hongfeng Liang

Since Specialization
Citations

This map shows the geographic impact of Hongfeng Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongfeng Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongfeng Liang more than expected).

Fields of papers citing papers by Hongfeng Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongfeng Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongfeng Liang. The network helps show where Hongfeng Liang may publish in the future.

Co-authorship network of co-authors of Hongfeng Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Hongfeng Liang. A scholar is included among the top collaborators of Hongfeng Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongfeng Liang. Hongfeng Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Ting, Zhe Li, Hongfeng Liang, et al.. (2025). Identifying Immune Response Protein Biomarkers in Parkinson’s-Related Cognitive Impairment and Depression. Molecular Neurobiology. 62(9). 11890–11903. 1 indexed citations
2.
Liang, Hongfeng, et al.. (2025). Discrete truncation method for measuring the cardiac t2* values in patients with thalassemia. Annals of Medicine. 57(1). 2460190–2460190.
3.
Liang, Hongfeng, Fen Lin, Yikang Yang, et al.. (2024). Molecular epidemiological investigation of G6PD deficiency in Yangjiang region, western Guangdong province. Frontiers in Genetics. 14. 1345537–1345537. 1 indexed citations
4.
5.
Liang, Hongfeng, Wei Zhang, Qiang Wang, et al.. (2023). β‐Sitosterol Suppresses LPS‐Induced Cytokine Production in Human Umbilical Vein Endothelial Cells via MAPKs and NF‐κB Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2023(1). 9241090–9241090. 4 indexed citations
6.
Liang, Hongfeng, Wenguang Xie, Fen Lin, et al.. (2023). The gene spectrum of thalassemia in Yangjiang of western Guangdong Province. Frontiers in Genetics. 14. 1126099–1126099. 5 indexed citations
8.
Huang, Quanfei, Yuwei Liao, Lei Wei, et al.. (2023). A retrospective analysis of preemptive pharmacogenomic testing in 22,918 individuals from China. Journal of Clinical Laboratory Analysis. 37(5). e24855–e24855. 10 indexed citations
9.
Wang, Xiaodong, Jun Jiang, Haiyuan Chen, et al.. (2023). Generation of Vgll4‐DreER transgenic mouse for visualizing and manipulating VGLL4‐expressing cells in vivo. Journal of Biochemical and Molecular Toxicology. 37(10). e23435–e23435.
10.
Liang, Hongfeng, et al.. (2022). Glucose-6-phosphate dehydrogenase deficiency screening and gene analysis in blood donors of Guangdong province. Hematology. 27(1). 494–498. 3 indexed citations
11.
Liang, Hongfeng, Liejun Li, Hui Yang, et al.. (2022). Clinical validation of a single-tube PCR and reverse dot blot assay for detection of common α-thalassaemia and β-thalassaemia in Chinese. Journal of International Medical Research. 50(2). 3629139713–3629139713. 6 indexed citations
12.
Zhang, Wei, Qiang Wang, Xuefeng Jiang, et al.. (2021). Systems pharmacological study based on UHPLC-Q-Orbitrap-HRMS, network pharmacology and experimental validation to explore the potential mechanisms of Danggui-Shaoyao-San against atherosclerosis. Journal of Ethnopharmacology. 278. 114278–114278. 22 indexed citations
13.
Jin, Cheng‐Jie, Rui Jiang, Hongfeng Liang, Dawei Li, & Hao Wang. (2019). The similarities and differences between the empirical and experimental data: investigation on the single-lane traffic. Transportmetrica B Transport Dynamics. 7(1). 1323–1337. 4 indexed citations
14.
Zhang, Xinchun, et al.. (2019). YY1/LncRNA GAS5 complex aggravates cerebral ischemia/reperfusion injury through enhancing neuronal glycolysis. Neuropharmacology. 158. 107682–107682. 50 indexed citations
15.
Fan, Huijie, Xiaoshan Zhao, Zhang‐Bin Tan, et al.. (2019). Effects and mechanism of action of Huang-Lian-Jie-Du-Tang in atopic dermatitis-like skin dysfunction in vivo and in vitro. Journal of Ethnopharmacology. 240. 111937–111937. 27 indexed citations
16.
Zhang, Xinchun, Hongfeng Liang, Xiaodong Luo, et al.. (2018). YY1 promotes IL-6 expression in LPS-stimulated BV2 microglial cells by interacting with p65 to promote transcriptional activation of IL-6. Biochemical and Biophysical Research Communications. 502(2). 269–275. 25 indexed citations
17.
Zhou, Wei, et al.. (2017). Proteomic analysis of chondromodulin-I-induced differentiation of mesenchymal stem cells into chondrocytes. Journal of Proteomics. 159. 1–18. 4 indexed citations
18.
Su, Qiaozhen, Hongfeng Liang, Chang An, Zhe Li, & Xiaodong Luo. (2016). [Pathogenesis of Parkinson's Disease Viewing from Modern Chinese Medicine].. PubMed. 36(12). 1515–1517. 1 indexed citations
19.
Song, Mingzhi, Wei Dai, Hongfeng Liang, et al.. (2016). Giant cell tumor of the patella with a secondary aneurysmal bone cyst: A case report. Oncology Letters. 11(6). 4045–4048. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026